Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Graft vs Host Disease × treosulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 10 Leukemia, Myeloid, Acute 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hemoglobinuria, Paroxysmal 1 Graft vs Host Disease 1

Interventions

Cyclophosphamide 58 Tacrolimus 46 Methotrexate 42 Cyclosporine 33 Mycophenolic Acid 32 Busulfan 30 Antilymphocyte Serum 30 fludarabine phosphate 29 fludarabine 26 Sirolimus 24 Radiotherapy 19 Methylprednisolone 19 Melphalan 18 Whole-Body Irradiation 16 Peripheral Blood Stem Cell Transplantation 16 thymoglobulin 14 Filgrastim 14 Stem Cell Transplantation 9 Rituximab 8 ruxolitinib 7 Thiotepa 7 Prednisone 7 Hematopoietic Stem Cell Transplantation 6 Granulocyte Colony-Stimulating Factor 6 Etoposide 6 Cytarabine 6 Cord Blood Stem Cell Transplantation 6 Pentostatin 5 Cyclosporins 5 Alemtuzumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01810926 2013-03-14

T&B Depletion Non Malignant

Bambino Gesù Hospital and Research Institute

Phase 2 Unknown

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡